OUTCOMES OF CHILDREN WITH HEMATOLOGIC MALIGNANCIES WHO RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION AND POST-HCT MINIMAL RESIDUAL DISEASE

被引:0
|
作者
Shah, Nirali [1 ]
Borowitz, Michael [1 ]
Robey, Nancy [1 ]
Gamper, Christopher [1 ]
Symons, Heather [1 ]
Loeb, David [1 ]
Wayne, Alan [1 ]
Chen, Allen [1 ]
机构
[1] NIH, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S98 / S98
页数:1
相关论文
共 50 条
  • [1] Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation
    Shah, Nirali N.
    Borowitz, Michael J.
    Robey, Nancy
    Gamper, Christopher
    Symons, Heather J.
    Loeb, David
    Wayne, Alan S.
    Chen, Allen R.
    BLOOD, 2012, 120 (21)
  • [2] Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
    Shah, Nirali
    Borowitz, Michael J.
    Robey, Nancy
    Gamper, Christopher
    Symons, Heather
    Loeb, David
    Wayne, Alan S.
    Chen, Allen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S306 - S306
  • [3] Outcome of Children Who Experience Disease Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
    Bajwa, Rajiinder P. S.
    Soni, Sandeep
    Schechter, Tal
    Gassas, Adam
    Doyle, John J.
    Sisler, India
    Godder, Kamar
    Tatman, David
    Rumelhart, Stephen
    Domm, Jennifer
    Frangoul, Haydar
    BLOOD, 2011, 118 (21) : 1751 - 1751
  • [4] Outcomes after Second Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies
    Huselton, Eric
    Slade, Michael
    Abboud, Camille
    Cashen, Amanda
    DiPersio, John F.
    Ghobadi, Armin
    Pusic, Iskra
    Romee, Rizwan
    Uy, Geoffrey L.
    Vij, Ravi
    Westervelt, Peter
    Schroeder, Mark A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S278 - S278
  • [5] Factors Predictive of Relapse of Hematologic Malignancies in Pediatric Patients Post Allogeneic Hematopoietic Cell Transplantation
    Shah, Nirali N.
    Borowitz, Michael J.
    Steinberg, Seth M.
    Lefell, Mary
    Robey, Nancy
    Gamper, Christopher
    Symons, Heather J.
    Loeb, David
    Wayne, Alan S.
    Chen, Allen R.
    BLOOD, 2012, 120 (21)
  • [6] Outcome of children who experience disease relapse following allogeneic hematopoietic SCT for hematologic malignancies
    Bajwa, R.
    Schechter, T.
    Soni, S.
    Gassas, A.
    Doyle, J.
    Sisler, I.
    Godder, K.
    Tatman, D.
    Rumelhart, S.
    Domm, J.
    Miao, Y.
    Frangoul, H.
    BONE MARROW TRANSPLANTATION, 2013, 48 (05) : 661 - 665
  • [7] Outcome of children who experience disease relapse following allogeneic hematopoietic SCT for hematologic malignancies
    R Bajwa
    T Schechter
    S Soni
    A Gassas
    J Doyle
    I Sisler
    K Godder
    D Tatman
    S Rumelhart
    J Domm
    Y Miao
    H Frangoul
    Bone Marrow Transplantation, 2013, 48 : 661 - 665
  • [8] Second Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies for Relapse After First Allografts
    Gyurkocza, Boglarka
    Storb, Rainer
    Chauncey, Thomas
    Maloney, David G.
    Storer, Barry
    Sandmaier, Brenda M.
    BLOOD, 2012, 120 (21)
  • [9] Pre-Hematopoietic Cell Transplant (HCT) Disease Status and Early Post-HCT Bone Marrow (BM) Chimerism Remain Predictors of Leukemia Relapse in Children Who Receive Preemptive Post-HCT Immunomodulatory Therapy (IT)
    Horn, Biljana
    Petrovic, Aleksandra
    Wahlstrom, Justin T.
    Dvorak, Christopher C.
    Kong, Denice
    Exposer-Spencer, Jueleah
    Cowan, Morton J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S82 - S83
  • [10] FACTORS PREDICTIVE OF RELAPSE OF HEMATOLOGIC MALIGNANCIES IN PEDIATRIC PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (ALLOHCT)
    Shah, Nirali
    Borowitz, Michael
    Steinberg, Seth
    Robey, Nancy
    Gamper, Christopher
    Loeb, David
    Symons, Heather
    Wayne, Alan
    Chen, Allen
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S96 - S96